Bioanalytical testing refers to analytical methods and techniques that are used to quantitatively measure drugs, metabolites, biomarkers, or biomarkers of exposure in biological matrices like plasma, serum, urine, or tissue homogenates. These techniques play a vital role in drug development and are crucial for evaluating pharmacokinetic studies and clinical trial results. Bioanalytical testing is required at various stages of drug development including pre-clinical, clinical, and post-marketing.
Regulatory Requirements for Bioanalytical Methods
Regulatory agencies like the FDA and EMA have stringent guidelines and criteria for method validation of bioanalytical techniques used in quantifying drugs and metabolites in biological matrices. Key validation characteristics that must be demonstrated include specificity, selectivity, precision, accuracy, reproducibility, calibration curve, lower limit of quantification, dilution integrity, benchtop stability, freeze-thaw stability etc. Validation results must be documented in a bioanalytical method report and be made available for regulatory review if requested. Any changes made to a validated bioanalytical method also require re-validation.
Sample Preparation Techniques
Proper sample preparation is crucial for Bioanalytical Testing as it ensures efficient extraction of analytes from biological matrices prior to analysis. Common sample preparation techniques include protein precipitation, liquid-liquid extraction, solid phase extraction etc. Technique chosen depends on analyte properties, matrix type, selectivity/sensitivity needs. Sample preparation must effectively extract analytes while removing potential interfering matrix components. Automated liquid handling workstations are commonly used to streamline high throughput sample preparation for clinical studies.
Instrumental Techniques for Analysis
Following are some key instrumental techniques used for quantifying drugs/metabolites in bioanalytical testing:
Liquid Chromatography-Mass Spectrometry (LC-MS/MS): Considered the gold standard technique due to its high selectivity and sensitivity. LC separation coupled with MS/MS detection enables reliable quantification of analytes even at low pg/mL levels in complex matrices. LC-MS/MS bioanalytical methods have largely replaced immunoassays.
Liquid Chromatography with UV detection (LC-UV): Used for analytes that do not require extremely high sensitivity. UV detectors are simple and robust but lack the selectivity of mass spectrometry.
Immunoassays: Techniques like ELISA, RIA were previously commonly used but have been replaced by LC-MS/MS for most applications due to superior performance. Immunoassays still find some use in specific scenarios.
Other techniques like gas chromatography-mass spectrometry (GC-MS) are also used but to a lesser extent than LC-MS/MS. Selection of appropriate technique depends on analyte properties and method performance requirements.
Method Validation and Reporting
As per regulatory guidelines, validation of a new bioanalytical method must be performed to demonstrate it is reliable, reproducible and fit-for-purpose prior to sample analysis. Key validation characteristics evaluated include:
– Selectivity: Assess for interference from blank matrix and ensure analyte can be reliably quantified.
– Calibration curve: Establish linear response over concentration range and ensure back-calculated standards meet accuracy criteria.
– Accuracy and precision: Determine inter- and intra-assay accuracy and precision using quality control samples.
– Lower limit of quantification: Establish lowest concentration level that meets precision and accuracy criteria.
– Recovery: Assess extraction efficiency of analyte from matrix.
– Stability: Evaluate stability of analyte under various conditions like freeze-thaw, bench-top, stock solution etc.
Detailed validation results and documentation as per regulatory format is essential. Any subsequent changes to method also necessitate re-validation. Well validated bioanalytical methods are critical to ensuring reliability of clinical trial data.
Bioanalytical Testing Services
Due to complex nature of analyses and stringent regulatory needs, most pharmaceutical/biotech companies outsource bioanalytical work to specialized contract research organizations (CROs) providing bioanalytical testing services. Key services provided by such CROs include:
– Development and validation of new bioanalytical methods for drugs/metabolites across various matrices.
– Sample analysis using validated methods to support pharmacokinetic, bioavailability, bioequivalence and clinical studies.
– Detailed method validation report preparation adhering to FDA/EMA guidance.
– Incurred sample reanalysis to confirm reproducibility of analytical runs.
– Stability indicating method development for analytes prone to instability.
– Qualified analysts, state-of-art instrumentation and optimized automated sample preparation workflows for high throughput analyses.
– Expert data review, integration and reporting to sponsors as per study needs.
– Analytical support for late phase clinical trials, generic applications and routine therapeutic monitoring.
Leading bioanalytical CROs have extensive experience, industry recognized certifications like GLP and adhere to global quality standards to help clients meet regulatory standards through reliable, timely bioanalysis outsourcing services. This enables sponsors to focus core competencies while ensuring quality bioanalytical data generation.
In conclusion, well developed and validated bioanalytical methods coupled with high quality sample analysis services provide a foundation for evidence generation from pharmacokinetic and clinical studies. By selecting reputed CROs with demonstrated expertise in developing robust assays, method validation and data reporting as per regulatory standards, biopharma companies can be assured of quality analytical support enabling on-time product development timelines. Outsourced bioanalysis services thus serve as a reliable, efficient alternative to in-house capabilities especially for smaller to mid-size firms.
Get more insights on Bioanalytical Testing
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
